Your browser doesn't support javascript.
loading
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis.
Radich, Jerald P; Wall, Matthew; Branford, Susan; Campbell, Catarina D; Chaturvedi, Shalini; DeAngelo, Daniel J; Deininger, Michael; Guinney, Justin; Hochhaus, Andreas; Hughes, Timothy P; Kantarjian, Hagop M; Larson, Richard A; Li, Sai; Maegawa, Rodrigo; Mishra, Kaushal; Obourn, Vanessa; Pinilla-Ibarz, Javier; Purkayastha, Das; Sadek, Islam; Saglio, Giuseppe; Shrestha, Alok; White, Brian S; Druker, Brian J.
Afiliación
  • Radich JP; Fred Hutchinson Cancer Research Center, Seattle, WA. jradich@fredhutch.org.
  • Wall M; Sage Bionetworks, Seattle, WA.
  • Branford S; SA Pathology, Centre for Cancer Biology, Adelaide, SA.
  • Campbell CD; Novartis Institutes for Biomedical Research, Cambridge, MA.
  • Chaturvedi S; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • DeAngelo DJ; Dana-Farber Cancer Institute, Boston, MA.
  • Deininger M; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.
  • Guinney J; Sage Bionetworks, Seattle, WA.
  • Hochhaus A; Universitätsklinikum Jena, Jena.
  • Hughes TP; South Australian Health and Medical Research Institute and University of Adelaide, Adelaide.
  • Kantarjian HM; MD Anderson Cancer Center, University of Texas, Houston, TX.
  • Larson RA; Medicine- Hematology/Oncology, University of Chicago.
  • Li S; Novartis Pharmaceuticals Corporation, Basel, Basel-Stadt.
  • Maegawa R; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Mishra K; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Obourn V; Novartis Institutes for Biomedical Research, Cambridge, MA.
  • Pinilla-Ibarz J; Moffitt Cancer Center, University of South Florida, Tampa, FL.
  • Purkayastha D; Novartis Pharmaceuticals Corporation, Basel, Basel-Stadt.
  • Sadek I; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Saglio G; University of Turin, Turin, Italy.
  • Shrestha A; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • White BS; Sage Bionetworks, Seattle, WA.
  • Druker BJ; Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
Haematologica ; 108(6): 1567-1578, 2023 06 01.
Article en En | MEDLINE | ID: mdl-36727397
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Leucemia Mieloide de Fase Crónica / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Leucemia Mieloide de Fase Crónica / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article